Indications
- Acute, Glucocorticoid-Resistant Rejection of Allogeneic Renal, Heart and Liver Transplants: FDA-approved for these indications
Pharmacology
- Monoclonal Antibody Against T-Cell CD3 Receptor
- OKT3 was the first monoclonal antibody to be approved for clinical use in humans
Adverse Effects
- Cytokine Release Syndrome (see Cytokine Release Syndrome, [[Cytokine Release Syndrome]])
References
- xxx